Ryu Kasai

2PUBLICATIONS
3CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jan 04, 2018
Long-term safety and efficacy of emicizumab in a phase 1/2 study in patients with hemophilia A with or without inhibitors.

Midori Shima, Hideji Hanabusa, Masashi Taki

|Dec 08, 2017
A Pharmacometric Approach to Substitute for a Conventional Dose-Finding Study in Rare Diseases: Example of Phase III Dose Selection for Emicizumab in Hemophilia A.

Koichiro Yoneyama, Christophe Schmitt, Naoki Kotani

Pageof 1

Frequent Collaborators

2 joint publications

Koichiro Yoneyama

1 joint publications

Christophe Schmitt

1 joint publications

Hiroki Yoshida